Critical Care & Emergencies (all articles)
Blood Type Linked to Outcomes in Covid-19 Patients: Type O May Be Protective and Type A May Increase Risk
18 Jun, 2020 | 09:12h | UTCCommentary: Study ties blood type to COVID-19 risk; O may help, A hurt – Associated Press
Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure
18 Jun, 2020 | 09:07h | UTCInvited Commentary: Prone Positioning in Awake, Nonintubated Patients With COVID-19: Necessity Is the Mother of Invention – JAMA Internal Medicine
ACP Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination with Azithromycin for the Prophylaxis or Treatment of COVID-19?
18 Jun, 2020 | 08:59h | UTC
WHO To Include Dexamethasone in Updated COVID-19 Care Guidelines; Drops Hydroxychloroquine from Massive Solidarity Trial
18 Jun, 2020 | 09:02h | UTCSee also: WHO drops hydroxychloroquine from Covid-19 clinical trial – STAT AND WHO halts malaria drug study, eyes steroid for COVID-19 – CIDRAP AND Steroid should be kept for serious coronavirus cases, WHO says – Reuters
Position Paper: Guidance on Diagnosis, Prevention and Treatment of Thromboembolic Complications in COVID-19
18 Jun, 2020 | 09:03h | UTC
Study Commentary: Haloperidol for Headache – THE HA Study RCT
18 Jun, 2020 | 08:44h | UTCHaloperidol for Headache – THE HA Study RCT – Journal Feed
Original Study: Treatment of Headache in the Emergency Department: Haloperidol in the Acute Setting (THE-HA Study): A Randomized Clinical Trial – The Journal of Emergency Medicine (link to abstract – $ for full-text)
Randomized Trial: Dexamethasone Reduces Death by Up to One Third in Patients with Severe COVID-19
17 Jun, 2020 | 02:49h | UTCCommentaries: Coronavirus breakthrough: dexamethasone is first drug shown to save lives – Nature AND WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 patients – World Health Organization AND Major study finds common steroid reduces deaths among patients with severe Covid-19 – STAT AND Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 – University of Oxford AND Coronavirus: Dexamethasone proves first life-saving drug – BBC
Related Commentary on Twitter
Dexamethasone reduced deaths by 1/3rd in ventilated patients (rate ratio 0.65 [95% CI 0.48 to 0.88]; p=0.0003) and by 1/5th in patients receiving oxygen only (0.80 [0.67 to 0.96]; p=0.0021). No benefit in patients not requiring respiratory support (1.22 [0.86 to 1.75; p=0.14).
— Peter Horby @peterhorby.bsky.social (@PeterHorby) June 16, 2020
CDC Report: Hospitalizations for Covid-19 Six Times Higher and Deaths 12 times Higher Among Those with Underlying Conditions
16 Jun, 2020 | 08:19h | UTCCommentary: COVID-19 patients with underlying health conditions are 12 times more likely to die: CDC – The Hill
COVID-19 Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
16 Jun, 2020 | 08:10h | UTCCommentaries: FDA Withdraws Emergency Use Authorization For Hydroxychloroquine – NPR AND FDA revokes authorization of drug Trump touted – CNN
Thromboelastographic Results and Hypercoagulability Syndrome in Patients with Coronavirus Disease 2019 Who Are Critically Ill
16 Jun, 2020 | 07:58h | UTC
Randomized Trial: Ruxolitinib for the Treatment of Severe COVID-19
16 Jun, 2020 | 07:55h | UTCCommentary: Multicenter RCT evaluating ruxolitinib (a JAK inhibitor) for COVID-19 – PulmCrit
Editorial: How I Approach Weaning from Venoarterial ECMO
16 Jun, 2020 | 07:49h | UTCHow I approach weaning from venoarterial ECMO – Critical Care
Neuropathological Features of Covid-19
15 Jun, 2020 | 03:35h | UTCNeuropathological Features of Covid-19 – New England Journal of Medicine
Review: Acute Kidney Injury in Critically ill Patients with COVID-19
15 Jun, 2020 | 03:41h | UTCAcute kidney injury in critically ill patients with COVID-19 – Intensive Care Medicine
European Resuscitation Council COVID-19 Guidelines: Executive Summary
15 Jun, 2020 | 03:42h | UTCEuropean Resuscitation Council COVID-19 Guidelines Executive Summary – Resuscitation
A Systematic Review of Neurological Manifestations of SARS‐CoV‐2 Infection
15 Jun, 2020 | 03:37h | UTC
COVID ‐19: A Global Threat to the Nervous System
15 Jun, 2020 | 03:39h | UTCCOVID ‐19: a global threat to the nervous system – Annals of Neurology
Commentary: COVID-19 threatens the entire nervous system – Northwestern University
Covid-19: Appropriate PPE Prevents Infections in Doctors in Frontline Roles, Study Shows
12 Jun, 2020 | 09:23h | UTCCovid-19: Appropriate PPE prevents infections in doctors in frontline roles, study shows – The BMJ
Covid-19 Patient Gets Double Lung Transplant, Offering Hope for Others
12 Jun, 2020 | 09:14h | UTCCovid-19 Patient Gets Double Lung Transplant, Offering Hope for Others – The New York Times
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection
12 Jun, 2020 | 09:11h | UTCCommentary: Myocardial Injury Seen in Over One-Third of Hospitalized COVID-19 Patients – TCTMD
Why, When, and How to Use Lung Ultrasound During the COVID-19 Pandemic
11 Jun, 2020 | 09:46h | UTC
Guideline: Prone Position Ventilation in Non-Intubated, Spontaneously Ventilating Patients
11 Jun, 2020 | 09:47h | UTC
Risks to Healthcare Workers Following Tracheal Intubation of Patients with COVID‐19
11 Jun, 2020 | 09:45h | UTC
Related Commentary on Twitter
Our first paper is now online as an early access article published in @Anaes_Journal
Headline: about 1 in 10 healthcare workers involved in performing tracheal intubation developed COVID-19 related outcomes in the ~1 month after first intubating. https://t.co/JOXKGXiOtm
— intubateCOVID (@IntubateCovid) June 10, 2020
Guidance on Acute Management of Atrial Fibrillation in COVID‐19
11 Jun, 2020 | 09:34h | UTC
The Spectrum of Cardiac Manifestations in COVID-19 – A Systematic Echocardiographic Study
11 Jun, 2020 | 09:32h | UTCCommentary: Echocardiograms Detail COVID-19’s Effects on the Heart – NEJM Journal Watch